Anna Laura Pasqui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Laura Pasqui has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- F. Bruni
Department of Clinical Medicine and Immunological Sciences, Medical Semeiotics Section, Policlinico Le Scotte, University of Siena, V.le Bracci, I-53100, Siena, Italy
17 shared publications A Auteri
15 shared publications- Luca Puccetti
University of Siena Centre for Atherosclerosis Research Siena Italy
14 shared publications A. Auteri
9 shared publicationsM Di Renzo
8 shared publications- M. Pastorelli
“Azienda Ospedaliera Universitaria Senese
8 shared publications
Latest Publications
- Open Access
- 9 May 2010
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2010, 1-8
Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling
Objectives. Cytokines play an important role in left ventricular remodeling consequent to myocardial ischemia. The aim of this study was to correlate cytokine production and lymphocyte apoptosis to post-ischemic left ventricular remodeling in patients affected by acute myocardial infarction (AMI) undergoing primary cutaneous angioplasty (PCI).Methods. In 40 patients, affected by AMI and undergoing PCI, we evaluated peripheral blood mononuclear cells (PBMCs), tumor necrosis factor-alpha (TNF-) and interleukin 10 (IL10) production and apoptosis on day 1, day 3, day 7, 1 month and 6 months after PCI. Patients were divided into two subgroups of remodeling or not remodeling by echocardiographic criteria.Results. In the subgroup of remodeling patients, at each timepoint TNF- production was increased significantly in comparison with the subgroup of not remodeling patients. IL10 production was statistically lower in remodeling subjects than in not remodeling ones 1 and 6 months after reperfusion. There were no differences between the two groups as regards lymphomonocyte apoptosis.Conclusions. We found an increased production of pro-inflammatory cytokine TNF- and a corresponding decrease of anti-inflammatory/regulatory cytokine IL10 in remodeling patients and we concluded that this cytokine imbalance resulted in pro-inflammatory effects which might contribute to the progression of left ventricular remodeling.
- 9 May 2010
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2010, 1-8
Open AccessPro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling
Objectives. Cytokines play an important role in left ventricular remodeling consequent to myocardial ischemia. The aim of this study was to correlate cytokine production and lymphocyte apoptosis to post-ischemic left ventricular remodeling in patients affected by acute myocardial infarction (AMI) undergoing primary cutaneous angioplasty (PCI).Methods. In 40 patients, affected by AMI and undergoing PCI, we evaluated peripheral blood mononuclear cells (PBMCs), tumor necrosis factor-alpha (TNF-) and interleukin 10 (IL10) production and apoptosis on day 1, day 3, day 7, 1 month and 6 months after PCI. Patients were divided into two subgroups of remodeling or not remodeling by echocardiographic criteria.Results. In the subgroup of remodeling patients, at each timepoint TNF- production was increased significantly in comparison with the subgroup of not remodeling patients. IL10 production was statistically lower in remodeling subjects than in not remodeling ones 1 and 6 months after reperfusion. There were no differences between the two groups as regards lymphomonocyte apoptosis.Conclusions. We found an increased production of pro-inflammatory cytokine TNF- and a corresponding decrease of anti-inflammatory/regulatory cytokine IL10 in remodeling patients and we concluded that this cytokine imbalance resulted in pro-inflammatory effects which might contribute to the progression of left ventricular remodeling.
- Open Access
- 24 January 2010
- Published by Wiley in Mediators of Inflammation
- Vol. 2010, 1
Erratum to “Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling”
- 24 January 2010
- Published by Wiley in Mediators of Inflammation
- Vol. 2010, 1
Open AccessErratum to “Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling”
- 30 November 2009
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 19, S24
[96] THE ROLE OF CYTOKINES IN LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION
- 30 November 2009
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 19, S24
[96] THE ROLE OF CYTOKINES IN LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION
- 30 November 2009
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 19, S20
[78] VIDEOCAPILLAROSCOPY (VCP) UTILITY IN DISEASES OF INTERNAL MEDICINE CHARACTER
- 30 November 2009
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 19, S20
[78] VIDEOCAPILLAROSCOPY (VCP) UTILITY IN DISEASES OF INTERNAL MEDICINE CHARACTER
- 15 April 2009
- Vol. 13 (1) , 63-5
Refractory Takayasu arteritis successfully treated with infliximab.
Takayasu arteritis (TA) is a chronic inflammatory disease of large arteries which progressively develop stenosis, occlusion or aneurismal degeneration. Proinflammatory cytokines and, among these, tumor necrosis factor-alpha (TNF-alpha) are increased and play a pathogenetic role in the development of disease. Conventional therapy often fails to determine clinical remission and, in these cases, pathogenetic strategies with anti-TNF-alpha drugs have been proposed. Infliximab is a human-murine chimeric monoclonal antibody that specifically binds to and neutralizes soluble TNF-alpha. It is an effective treatment for rheumatoid arthritis, spondyloarthritis, Crohn's disease and ulcerative colitis and it has been recently proposed for the treatment of TA in patients refractory to conventional therapy. Here we report the case of a patient affected by Takayasu arteritis unresponsive to conventional therapy who was then treated with infliximab and obtained a clinical remission of the disease.
- 15 April 2009
- Vol. 13 (1) , 63-5
Refractory Takayasu arteritis successfully treated with infliximab.
Takayasu arteritis (TA) is a chronic inflammatory disease of large arteries which progressively develop stenosis, occlusion or aneurismal degeneration. Proinflammatory cytokines and, among these, tumor necrosis factor-alpha (TNF-alpha) are increased and play a pathogenetic role in the development of disease. Conventional therapy often fails to determine clinical remission and, in these cases, pathogenetic strategies with anti-TNF-alpha drugs have been proposed. Infliximab is a human-murine chimeric monoclonal antibody that specifically binds to and neutralizes soluble TNF-alpha. It is an effective treatment for rheumatoid arthritis, spondyloarthritis, Crohn's disease and ulcerative colitis and it has been recently proposed for the treatment of TA in patients refractory to conventional therapy. Here we report the case of a patient affected by Takayasu arteritis unresponsive to conventional therapy who was then treated with infliximab and obtained a clinical remission of the disease.
- 1 September 2007
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 37 (9) , 742-745
Increased TNF-? production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine
BACKGROUND: Inflammatory and/or immune activation occurs both in animal models (twitcher mice) and in the brain of patients with Globoid cell leukodystrophy (GLD) or Krabbe's disease (KD). In this study we evaluated in vitro the cytokine profile of KD patients and the effect of psychosine, the toxic metabolite which plays a role in the demyelination process in these patients. MATERIALS AND METHODS: We studied cytokine production by peripheral blood mononuclear cells (PBMCs) isolated from four KD patients, diagnosed on the basis of clinical criteria. Cells were cultured and stimulated with appropriate agents and the supernatants collected before and after the addition of psychosine. Tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and monocyte chemoattractant factor (MCP)-1) production was evaluated (ELISA method) and compared with a group of 10 normal subjects. RESULTS: We found a significant increase of TNF-alpha release by PBMCs of KD patients compared with healthy subjects; TNF-alpha production was significantly increased after LPS addition. Psychosine was able to induce a further significant increase (P < 0.05) only in cells obtained from KD patients and not from control subjects. No changes were found in IL-8 and MCP-1 production. CONCLUSIONS: The increased TNF-alpha production permits us to confirm the presence of an inflammatory-immune stimulus in KD patients, which may be induced and potentiated by the pathogenetic metabolite psychosine
- 1 September 2007
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 37 (9) , 742-745
Increased TNF-? production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine
BACKGROUND: Inflammatory and/or immune activation occurs both in animal models (twitcher mice) and in the brain of patients with Globoid cell leukodystrophy (GLD) or Krabbe's disease (KD). In this study we evaluated in vitro the cytokine profile of KD patients and the effect of psychosine, the toxic metabolite which plays a role in the demyelination process in these patients. MATERIALS AND METHODS: We studied cytokine production by peripheral blood mononuclear cells (PBMCs) isolated from four KD patients, diagnosed on the basis of clinical criteria. Cells were cultured and stimulated with appropriate agents and the supernatants collected before and after the addition of psychosine. Tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and monocyte chemoattractant factor (MCP)-1) production was evaluated (ELISA method) and compared with a group of 10 normal subjects. RESULTS: We found a significant increase of TNF-alpha release by PBMCs of KD patients compared with healthy subjects; TNF-alpha production was significantly increased after LPS addition. Psychosine was able to induce a further significant increase (P < 0.05) only in cells obtained from KD patients and not from control subjects. No changes were found in IL-8 and MCP-1 production. CONCLUSIONS: The increased TNF-alpha production permits us to confirm the presence of an inflammatory-immune stimulus in KD patients, which may be induced and potentiated by the pathogenetic metabolite psychosine
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 405
We-P11:270 Clinical and immunological effects of one-week treatment with intravenous iloprost in critical limb ischemia patients
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 405
We-P11:270 Clinical and immunological effects of one-week treatment with intravenous iloprost in critical limb ischemia patients
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 333
We-W44:3 Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphism is associated with increased rate of cardiovascular events during statin treatment
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 333
We-W44:3 Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphism is associated with increased rate of cardiovascular events during statin treatment
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 147
Mo-P6:460 3UTR/T polymorphism of lectin-like oxidized-LDL receptor-1 (LOX-1) influences antiplatelet activity of atorvastatin in hypercholesterolemic subjects
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 147
Mo-P6:460 3UTR/T polymorphism of lectin-like oxidized-LDL receptor-1 (LOX-1) influences antiplatelet activity of atorvastatin in hypercholesterolemic subjects